Abilify approved for irritability associated with autistic disorder - MPR
Links shared publicly online about this topic.
- 1,581total visits
Abilify approved for irritability associated with autistic disorder - MPR
empr.com —
View full resource at empr.com
Tags: Autism, Schizophrenia Medication, Antipsychotic Medication, Disease and Condition, Children's Health, FDA, Abilify, Bristol-Myers Squibb
Most Recently Shared on November 23, 2009 at 3:41 pm By:
MPR News: Abilify approved for irritability associated with autistic disorder: The FDA has approved Abilify (aripip... http://bit.ly/510cxX
Abilify (aripiprazole) Approved for Maintenance Treatment of Bipolar I Disorder as an Adjunct to Either Lithium or Valproate
drugs.com — “Abilify (aripiprazole) is used to treat schizophrenia, Bipolar I Disorder, depression and irritability associated with autistic disorder. Includes Abilify side effects, interactions and indications.” View full resource at drugs.com
Most Recently Shared on February 21, 2011 at 10:15 pm By:
Drugs and Devices OW OW Health
Abilify (aripiprazole) Approved for Maintenance Treatment of Bipolar I Disorder as an Adjunct to Either Li... http://bit.ly/fuFJIk #drug
Pervasive Developmental Disorder: eMedicine Pediatrics: Developmental and Behavioral
emedicine.medscape.com — “Overview: Pervasive developmental disorders (PDDs) include a spectrum of behavioral problems commonly associated with autism. The Diagnostic and Statistical Manual of Mental Disorders, 4th Edition (DSM-IV) includes autistic disorder, Rett syndrome, childhood disintegrative disorder, Asperger's disorder, and ...” View full resource at emedicine.medscape.com
Most Recently Shared on April 16, 2010 at 8:21 pm By:
Medscape Pediatrics Health Site and Pediatrics
Abilify now FDA approved for use in child autism. See the eMedicine article Pervasive Developmental Disorder. http://bit.ly/bmalwP
Advertisement
